Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 97-105

  Anderson, John M ^a   Heindl, Lisa M ^a   Bauman, Patricia A ^a,b   Ludi, Clint W ^a   Dalton, William S ^a   Cress, Anne E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYTOKERATIN; DOXORUBICIN; MELPHALAN; MITOMYCIN C; MITOXANTRONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESISTANCE; MOUSE; PHENOTYPE; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DNA; DNA DAMAGE; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; KERATINS; MICE; PHENOTYPE;

EID: 0030061927     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hedley, D. W. Flow cytometric assays of anticancer drug resistance (Review). Ann. N. Y. Acad. Sci., 677: 341-353, 1993.
2. Clynes, M. Cellular models for multiple drug resistance in cancer (Review). In Vitro Cell. Dev. Biol., 29A(Part 1): 171-179, 1993.
3. Deffie, A. M., Alam, T., Seneviratne, C., Beenken, S. W., Batra, J. K., Shea, T. C., Henner, W. D., and Goldenberg, G. J. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res., 48: 3595-3602, 1988.
4. Simon, S., Roy, D., and Schindler, M. Intracellular pH and the control of multidrug resistance [published erratum appears in Proc. Natl. Acad. Sci. USA, 91: 4101, 1994]. Proc. Natl. Acad. Sci. USA, 91: 1128-1132, 1994.
5. Dulhanty, A. M., Li, M., and Whitmore, G. F. Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation. Cancer Res., 49: 117-122, 1989.
6. Dalton, W. S., Cress, A. E., Alberts, D. S., and Trent, J. M. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Cancer Res., 48: 1882-1888, 1988.
7. Roberts, R. A., Cress, A. E., and Dalton, W. S. Persistent intracellular binding of mitoxantrone in a human colon carcinoma cell line. Biochem. Pharmacol., 38: 4283-4290, 1989.
8. Bauman, P. A., Dalton, W. S., Anderson, J. M., and Cress, A. E. Expression of cytokeratin confers multiple drug resistance. Proc. Natl. Acad. Sci. USA, 91: 5311-5314, 1994.
9. Datta, R., Manome, Y., Taneja, N., Boise, L. H., Weichselbaum, R., Thompson, C. B., Slapak, C. A., and Kufe, D. Overexpression of Bcl-xL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth & Differ., 6: 363-370, 1995.
10. Ling, Y. H., Priebe, W., and Perez-Soler, R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res., 53: 1845-1852, 1993.
11. Kulesh, D. A., Cecena, G., Darmon, Y. M., Vasseur, M., and Oshima, R. G. Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol. Cell. Biol., 9: 1553-1565, 1989.
12. Lu, X., and Lane, E. B. Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: specific domain functions in keratin stabilization and filament formation. Cell, 62: 681-696, 1990
13. Chan, R., Rossitto, P. V., Edwards, B. F., and Cardiff, R. D. Presence of proteolytically processed keratins in the culture medium of MCF-7 cells. Cancer Res., 46: 6353-6359, 1986.
14. Park, J. G., Kramer, B. S., Steinberg, S. M., Carmichael, J., Collins, J. M., Minna, J. D., and Gazdar, A. F. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res , 47: 5875-5879, 1987.
15. Blanco, F. J., Ochs, R. L., Schwarz, H., and Lotz, M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol., 146: 75-85, 1995.
16. Futscher, B. W., Pieper, R. O., Dalton, W. S., and Erickson, L. C. Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR. Cell Growth & Differ., 3: 217-223, 1992.
17. Chabner, B. A. Anticancer Drugs. In: V. T. Devita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, Ed. 4. Vol. 1, pp. 325-417. Philadelphia: J. B. Lippincott, 1993.
18. Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Hickman, J. A., Wakeling, A. E., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12: 3679-3684, 1993.
19. Gottesman, M. M., Mickisch, G. H., and Pastan, I. In vivo models of P-glycoprotein-mediated multidrug resistance. In: L. J. Goldstein and R. F. Ozols (eds.), Anticancer Drug Resistance: Advances in Molecular and Clinical Research, pp. 107-128. Boston: Kluwer Academic Publishers, 1994.
20. Akiyama, S., Fojo, A., Hanover, J. A., Pastan, I., and Gottesman, M. M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol. Genet., 11: 117-126, 1985.
21. Shen, D. W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., and Gottesman, M. M. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science (Washington DC), 232: 643-645, 1986.
22. Cole, S. P., Chanda, E. R., Dicke, F. P., Gerlach, J. H., and Mirski, S. E. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res, 51: 3345-3352, 1991.
23. Cole. S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
24. Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180, 525-535, 1994.
25. Demarcq, C., Bunch, R T., Creswell, D., and Eastman, A. The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells Cell Growth & Differ , 5: 983-993, 1994.
26. Kaufmann, S. H. Expression of nuclear envelope lamins A and C in human myeloid leukemias. Cancer Res., 52: 2847-2853, 1992.
27. Miyashita, T., and Reed, J. C. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52: 5407-5411, 1992.
28. Gunji, H., Kharbanda, S., and Kufe, D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res., 51: 741-743, 1991.
29. Rubin, E., Kharbanda, S., Gunji, H., and Kufe, D. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol. Pharmacol., 39: 697-701, 1991.
30. Manome, Y., Datta, R., Taneja, N., Shafman, T., Bump, E., Hass, R., Weichselbaum, R., and Kufe, D. Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation. Biochemistry, 32: 10607-10613, 1993.
31. Nagle, R. B. A review of intermediate filament biology and their use in pathologic diagnosis. Mol. Biol. Rep. 19: 3-21, 1994.
32. Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma (see comments) (published erratum appears in N. Engl. J. Med. 331: 139, 1994). N. Engl. J. Med. 330: 1253-1259, 1994.
33. Stupp, R., Weichselbaum, R. R., and Vokes, E. E. Combined modality therapy of head and neck cancer. Semin. Oncol., 21: 349-358, 1994.
34. Weinert, T., and Lydall, D. Cell cycle checkpoints, genetic instability and cancer. Semin. Cancer Biol., 4: 129-140, 1993.
35. Ibrado, A. M., Ponnathpur, V., Reed, J., Tang, C., Huang, Y., Ray, S., Bullock, G., Mahoney, M. E., and Bhalla, K. Protein kinase C and tyrosine kinase activities affect toxol induced apoptosis in human leukemic cells. Proc. Am. Assoc. Cancer Res., 35: 314, 1994.